Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| S-Trityl-L-Cysteine SCHEMBL768203 | 1.00 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL768202 | 1.00 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190175 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190178 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL655694 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL655692 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| SCHEMBL12851543 | 0.91 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537506 | 0.89 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL2838308 | 0.88 | KIF11 (0.68) | KIF11DNMT1 | |
| SCHEMBL7753308 | 0.88 | KIF11 (0.68) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478368-B | Synthesis method and application of chiral paramagnetic probe Py-D-Cys-DTPA | 南开大学 | 2024-09-20 | — | — | CN | claimed |
| CN-114716515-A | Polypeptide analogue and preparation method and application thereof | 深圳深创生物药业有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114478368-A | Synthesis method and application of chiral paramagnetic probe Py-D-Cys-DTPA | 南开大学 | 2022-05-13 | — | — | CN | claimed |
| CN-114262304-A | Synthesis method and application of bioluminescent fluorescein responding to Fe (II) ions | 武汉大学中南医院 | 2022-04-01 | — | — | CN | claimed |
| EP-4722229-A1 | ADAPTOR MOLECULES FOR TARGETED CELL IMMUNOTHERAPIES | Universität Zürich (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20260048157-A1 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY | PURDUE RESEARCH FOUNDATION (US) | 2026-02-19 | — | — | US | disclosed |
| US-12508319-B2 | Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2025-12-30 | — | — | US | disclosed |
| US-12485179-B2 | Cholecystokinin B receptor targeting for imaging and therapy | PURDUE RESEARCH FOUNDATION (US) | 2025-12-02 | — | — | US | disclosed |
| US-12397069-B2 | Fibroblast activation protein (FAP)-targeted imaging and therapy | PURDUE RESEARCH FOUNDATION (US) | 2025-08-26 | — | — | US | disclosed |
| CN-111225688-B | FBSA-based therapy and radiological imaging conjugates targeting carbonic anhydrase-positive cancers | 普渡研究基金会 | 2025-06-17 | — | — | CN | disclosed |
| EP-3672615-B1 | FBSA-BASED THERAPEUTIC AND RADIOIMAGING CONJUGATES TARGETING CARBONIC ANHYDRASE POSITIVE CANCERS | PURDUE RESEARCH FOUNDATION (US) | 2025-04-02 | — | — | EP | disclosed |
| CN-118725026-A | Glycopeptide targeting tumor-associated fibroblast activation protein, radionuclide marker and application thereof | 中国科学院上海药物研究所 | 2024-10-01 | — | — | CN | disclosed |
| US-20140037961-A1 | System For Purifying, Producing And Storing Biomolecules | ADC BIOTECHNOLOGY LIMITED (GB) | 2014-02-06 | — | — | US | disclosed |
| US-20140037961-A1 | System For Purifying, Producing And Storing Biomolecules | ADC BIOTECHNOLOGY LIMITED (GB) | 2014-02-06 | — | — | US | disclosed |
| EP-2508524-A2 | Indole compound | Takeda Pharmaceutical Company Limited (JP) | 2012-10-10 | — | — | EP | disclosed |
| US-20110033878-A1 | LUMINESCENT SUBSTRATE FOR LICIFERASE | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110033878-A1 | LUMINESCENT SUBSTRATE FOR LICIFERASE | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-0906015-A4 | LIVER RETENTION CLEARING AGENTS | NEORX CORP (US) | 2004-05-12 | — | — | EP | disclosed |
| EP-0906015-A1 | LIVER RETENTION CLEARING AGENTS | NEORX CORPORATION (US) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997046099-A1 | LIVER RETENTION CLEARING AGENTS | NEORX CORPORATION (US) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140037961-A1 | System For Purifying, Producing And Storing Biomolecules | CRHR2, HCRTR2, KDELR2 | KIF11 2538/4885DNMT1 2168/4885 |
| US-12508319-B2 | Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof | LHCGR, GNRHR, SSTR1 | KIF11 2418/4885DNMT1 4091/4885 |
| US-12485179-B2 | Cholecystokinin B receptor targeting for imaging and therapy | CCKBR, CCKAR, GRPR | KIF11 978/4885DNMT1 4649/4885 |
| US-20260048157-A1 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY | FAP, FIBP, FGFR1 | KIF11 3473/4885DNMT1 4108/4885 |
| US-12397069-B2 | Fibroblast activation protein (FAP)-targeted imaging and therapy | FAP, FIBP, FRS2 | KIF11 2134/4885DNMT1 4229/4885 |
| US-20110033878-A1 | LUMINESCENT SUBSTRATE FOR LICIFERASE | GLB1, LSS, NANS | KIF11 4818/4885DNMT1 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.